Hypertension Diagnostics Alpha and Beta Analysis
| HDIIDelisted Stock | USD 0 0.0008 38.10% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hypertension Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hypertension Diagnostics over a specified time horizon. Remember, high Hypertension Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hypertension Diagnostics' market risk premium analysis include:
Beta 2.22 | Alpha 0.75 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Hypertension |
Hypertension Diagnostics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hypertension Diagnostics market risk premium is the additional return an investor will receive from holding Hypertension Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hypertension Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hypertension Diagnostics' performance over market.| α | 0.75 | β | 2.22 |
Hypertension Diagnostics Fundamentals Vs Peers
Comparing Hypertension Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Hypertension Diagnostics' direct or indirect competition across all of the common fundamentals between Hypertension Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Hypertension Diagnostics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Hypertension Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Hypertension Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Hypertension Diagnostics to competition |
| Fundamentals | Hypertension Diagnostics | Peer Average |
| Return On Asset | 3.0E-4 | -0.14 |
| Profit Margin | (0.03) % | (1.27) % |
| Operating Margin | 0.0002 % | (5.51) % |
| Current Valuation | 5.26 M | 16.62 B |
| Shares Outstanding | 52.39 M | 571.82 M |
| Price To Earning | (0.03) X | 28.72 X |
| Price To Sales | 0.15 X | 11.42 X |
Hypertension Diagnostics Opportunities
Hypertension Diagnostics Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Hypertension Diagnostics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hypertension or other pink sheets. Alpha measures the amount that position in Hypertension Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hypertension Diagnostics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hypertension Diagnostics' short interest history, or implied volatility extrapolated from Hypertension Diagnostics options trading.
Build Portfolio with Hypertension Diagnostics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Hypertension Pink Sheet
If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Transaction History View history of all your transactions and understand their impact on performance |